Novo Nordisk A/S (NEO:NVON)

Novo Nordisk Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	366,594	553,744	609,536	412,016	324,220	206,601
Market Cap Growth	-46.81%	-9.15%	47.94%	27.08%	56.93%	16.64%
Enterprise Value	381,438	550,167	605,412	409,779	320,030	202,124
PE Ratio	16.14	27.45	37.19	38.16	35.07	23.41
PS Ratio	5.31	9.55	13.40	11.97	11.90	7.77
PB Ratio	9.86	19.32	29.21	25.38	23.68	15.58
P/TBV Ratio	26.46	85.58	67.43	65.10	60.74	23.12
P/FCF Ratio	25.39	37.56	37.45	31.75	34.42	21.39
P/OCF Ratio	13.53	22.92	28.58	26.86	30.45	18.99
EV/Sales Ratio	5.59	9.49	13.31	11.91	11.74	7.60
EV/EBITDA Ratio	10.56	18.78	27.97	25.98	25.93	16.48
EV/EBIT Ratio	11.48	19.69	29.53	27.87	27.92	17.83
EV/FCF Ratio	26.42	37.32	37.20	31.57	33.97	20.93
Debt / Equity Ratio	0.60	0.72	0.25	0.31	0.38	0.16
Debt / EBITDA Ratio	0.61	0.69	0.24	0.31	0.41	0.17
Debt / FCF Ratio	1.53	1.39	0.33	0.39	0.55	0.23
Asset Turnover	0.69	0.74	0.84	0.81	0.83	0.94
Inventory Turnover	1.22	1.20	1.26	1.29	1.24	1.16
Quick Ratio	0.53	0.52	0.62	0.67	0.65	0.64
Current Ratio	0.78	0.74	0.82	0.90	0.86	0.94
Return on Equity (ROE)	71.47%	80.77%	88.07%	72.00%	71.24%	69.70%
Return on Assets (ROA)	21.11%	22.41%	23.55%	21.69%	21.81%	25.01%
Return on Capital (ROIC)	42.81%	46.03%	53.89%	45.74%	43.27%	49.84%
Return on Capital Employed (ROCE)	55.30%	56.30%	72.30%	62.80%	62.30%	72.50%
Earnings Yield	6.19%	3.64%	2.69%	2.62%	2.85%	4.27%
FCF Yield	3.94%	2.66%	2.67%	3.15%	2.90%	4.67%
Payout Ratio	49.88%	43.71%	37.96%	45.57%	45.05%	47.75%
Buyback Yield / Dilution	0.46%	0.71%	1.10%	1.34%	1.58%	1.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.